Understanding how certain proteins are made in cancer and neurodegenerative diseases
Mechanism of stringent translation initiation: a probe for its biological relevance
This study is looking at how proteins begin their work in cells, especially focusing on signals that might lead to cancer and brain diseases, using yeast to help find unusual starting points in human genes that could cause problems, with the hope of improving understanding and treatment for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kansas State University NIH-funded |
| Lab location | 1 site (Manhattan, United States) |
| Project ID | NIH-10908580 on NIH RePORTER |
What this research studies
This research investigates the complex process of how proteins are initiated in cells, focusing on specific start signals that can lead to cancer and neurodegenerative disorders. By studying the model organism yeast, the researchers aim to identify non-standard start sites in human genes that may contribute to disease. They will analyze how these alternative start sites are regulated and how mutations in certain genes can affect protein production, potentially impacting patient outcomes. The research employs advanced genome-wide profiling techniques to gather data on these processes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with cancer or neurodegenerative disorders who may benefit from a better understanding of their disease mechanisms.
Not a fit: Patients with conditions unrelated to cancer or neurodegenerative disorders may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into cancer and neurodegenerative diseases, potentially improving diagnosis and treatment options for patients.
How similar studies have performed: Previous research has shown promise in understanding translation initiation mechanisms, particularly in cancer, suggesting that this approach may yield valuable insights.
Where this research is happening
Manhattan, United States
- Kansas State University — Manhattan, United States (Active)
Researchers
- Principal investigator: Asano, Katsura — Kansas State University
- Study coordinator: Asano, Katsura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.